Literature DB >> 16325674

Management of low birth weight infants with congenital heart disease.

Anne Ades1, Beth Ann Johnson, Stuart Berger.   

Abstract

Low birth weight infants with congenital heart disease (CHD) have a higher mortality risk and likely a higher morbidity risk than their preterm or appropriate for gestational age counterparts without CHD and term counterparts with CHD. As our understanding of the pathophysiology and treatment of the diseases associated with prematurity and growth restriction improves, the outcomes for these infants should continue to improve. In addition, as more of these infants survive and are referred for surgery, operative techniques and strategies are likely to continue to improve. At this time, there is no adequate evidence that mortality is improved by delaying surgery for weight gain or performing palliative operations initially. Given the challenging physiology in this population, optimal management includes early referral to a tertiary or quaternary facility and a multidisciplinary team approach consisting of cardiologists, neonatologists, surgeons, nurses, perfusionists, and anesthesiologists.

Entities:  

Mesh:

Year:  2005        PMID: 16325674     DOI: 10.1016/j.clp.2005.09.001

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  9 in total

1.  Early and mid-term outcome of the arterial switch operation in 114 consecutive patients : A single centre experience.

Authors:  C Prandstetter; A Hofer; E Lechner; R Mair; E Sames-Dolzer; G Tulzer
Journal:  Clin Res Cardiol       Date:  2007-08-13       Impact factor: 5.460

2.  Congenital Heart Disease in Premature Infants 25-32 Weeks' Gestational Age.

Authors:  Patricia Y Chu; Jennifer S Li; Andrzej S Kosinski; Christoph P Hornik; Kevin D Hill
Journal:  J Pediatr       Date:  2016-11-03       Impact factor: 4.406

3.  The importance of small for gestational age in the risk assessment of infants with critical congenital heart disease.

Authors:  Anthony A Sochet; Mark Ayers; Emilio Quezada; Katherine Braley; Jennifer Leshko; Ernest K Amankwah; James A Quintessenza; Jeffrey P Jacobs; Gul Dadlani
Journal:  Cardiol Young       Date:  2013-12       Impact factor: 1.093

4.  Younger gestational age is associated with worse neurodevelopmental outcomes after cardiac surgery in infancy.

Authors:  Donna A Goff; Xianqun Luan; Marsha Gerdes; Judy Bernbaum; Jo Ann D'Agostino; Jack Rychik; Gil Wernovsky; Daniel J Licht; Susan C Nicolson; Robert R Clancy; Thomas L Spray; J William Gaynor
Journal:  J Thorac Cardiovasc Surg       Date:  2012-03       Impact factor: 5.209

5.  3-D volumetric MRI evaluation of the placenta in fetuses with complex congenital heart disease.

Authors:  Nickie Andescavage; Alexa Yarish; Mary Donofrio; Dorothy Bulas; Iordanis Evangelou; Gilbert Vezina; Robert McCarter; Adre duPlessis; Catherine Limperopoulos
Journal:  Placenta       Date:  2015-07-06       Impact factor: 3.481

6.  Congenital heart disease in low-birth-weight infants: effects of small for gestational age (SGA) status and maturity on postoperative outcomes.

Authors:  Daniel Wei; Colleen Azen; Shazia Bhombal; Laura Hastings; Lisa Paquette
Journal:  Pediatr Cardiol       Date:  2014-07-06       Impact factor: 1.655

7.  Clinical features and surgical outcomes of complete transposition of the great arteries.

Authors:  Suk Jin Hong; Hee Joung Choi; Yeo Hyang Kim; Myung Chul Hyun; Sang Bum Lee; Joon Yong Cho
Journal:  Korean J Pediatr       Date:  2012-10-29

Review 8.  What is new in pediatric cardiac imaging?

Authors:  Luc Mertens; Javier Ganame; Bénédicte Eyskens
Journal:  Eur J Pediatr       Date:  2007-07-10       Impact factor: 3.183

9.  Effect of Fetal Growth on 1-Year Mortality in Neonates With Critical Congenital Heart Disease.

Authors:  Martina A Steurer; Rebecca J Baer; Edmund Burke; Shabnam Peyvandi; Scott Oltman; Christina D Chambers; Mary E Norton; Larry Rand; Satish Rajagopal; Kelli K Ryckman; Sky K Feuer; Liang Liang; Randi A Paynter; Molly McCarthy; Anita J Moon-Grady; Roberta L Keller; Laura L Jelliffe-Pawlowski
Journal:  J Am Heart Assoc       Date:  2018-09-04       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.